14 hedge funds and large institutions have $1.15M invested in BiomX in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
1
Closed
3
Calls
$3K
Puts
Net Calls
+$3K
Net Calls Change
-$3K
Name Market Value Shares Shares
Change
Shares
Change %
O
1
OrbiMed
New York
$525K 2,813,489
JJ
2
Johnson & Johnson
New Jersey
$398K 2,133,402
MI
3
MMCAP International
Cayman Islands
$128K 684,451
Millennium Management
4
Millennium Management
New York
$51K 270,848 +183,091 +209%
Jane Street
5
Jane Street
New York
$11.2K 59,768
BCM
6
Bridgeway Capital Management
Texas
$9.24K 49,500 -9,200 -16%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$7.73K 41,409 +41,409 New
Renaissance Technologies
8
Renaissance Technologies
New York
$7K 39,400 +9,100 +30%
UBS Group
9
UBS Group
Switzerland
$5.68K 29,893 +26,152 +699%
Walleye Capital
10
Walleye Capital
New York
$2.53K 13,556
TSS
11
Two Sigma Securities
New York
$1.98K 10,624 +10,624 New
Walleye Trading
12
Walleye Trading
New York
$1.95K 10,422
BlackRock
13
BlackRock
New York
$1.07K 5,750
RA
14
Royce & Associates
New York
-158,655 Closed
VF
15
Virtu Financial
New York
-68,813 Closed
Citadel Advisors
16
Citadel Advisors
Florida
-31,945 Closed
Bank of America
17
Bank of America
North Carolina
$0 2
CFGS
18
Concourse Financial Group Securities
Alabama
JGC
19
J. Goldman & Co
New York